|
Clinical Trials and Observations
Citations 391-400 of 2742 total displayed.
|
Past content
(since May 1998):
|
Trends in long-term survival of patients with chronic lymphocytic leukemia from the 1980s to the early 21st century
- Hermann Brenner, Adam Gondos, and Dianne Pulte
Blood 2008; 111: 4916-4921.
[Abstract]
[Full text]
[PDF]
The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases
- Jean-Jacques Kiladjian, Francisco Cervantes, Franck W. G. Leebeek, Christophe Marzac, Bruno Cassinat, Sylvie Chevret, Dominique Cazals-Hatem, Aurélie Plessier, Juan-Carlos Garcia-Pagan, Sarwa Darwish Murad, Sebastian Raffa, Harry L. A. Janssen, Claude Gardin, Sophie Cereja, Carole Tonetti, Stéphane Giraudier, Bertrand Condat, Nicole Casadevall, Pierre Fenaux, and Dominique C. Valla
Blood 2008; 111: 4922-4929.
[Abstract]
[Full text]
[PDF]
Structural and numerical variation of FLT3/ITD in pediatric AML
- Soheil Meshinchi, Derek L. Stirewalt, Todd A. Alonzo, Titus J. Boggon, Robert B. Gerbing, Jennifer L. Rocnik, Beverly J. Lange, D. Gary Gilliland, and Jerald P. Radich
Blood 2008; 111: 4930-4933.
[Abstract]
[Full text]
[PDF]
Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)
- Sandra L. Haberichter, Giancarlo Castaman, Ulrich Budde, Ian Peake, Anne Goodeve, Francesco Rodeghiero, Augusto B. Federici, Javier Batlle, Dominique Meyer, Claudine Mazurier, Jenny Goudemand, Jeroen Eikenboom, Reinhard Schneppenheim, Jorgen Ingerslev, Zdena Vorlova, David Habart, Lars Holmberg, Stefan Lethagen, John Pasi, Frank G. H. Hill, and Robert R. Montgomery
Blood 2008; 111: 4979-4985.
[Abstract]
[Full text]
[PDF]
Complete molecular responses are achieved after reduced intensity stem cell transplantation and donor lymphocyte infusion in chronic myeloid leukemia
- Nicholas B. Heaney, Mhairi Copland, Karen Stewart, Judith Godden, Anne N. Parker, I. Grant McQuaker, Graeme M. Smith, Charles Crawley, Pat Shepherd, and Tessa L. Holyoake
Blood 2008; 111: 5252-5255.
[Abstract]
[Full text]
[PDF]
Environmental and genetic modifiers of the progression to fibrosis and cirrhosis in hemochromatosis
- Marnie J. Wood, Lawrie W. Powell, and Grant A. Ramm
Blood 2008; 111: 4456-4462.
[Abstract]
[Full text]
[PDF]
Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials
- Nathalie Mourad, Nicolas Mounier, Josette Brière, Emmanuel Raffoux, Alain Delmer, Alfred Feller, Chris J. L. M. Meijer, Jean-François Emile, Réda Bouabdallah, André Bosly, Jacques Diebold, Corinne Haioun, Bertrand Coiffier, Christian Gisselbrecht, and Philippe Gaulard
Blood 2008; 111: 4463-4470.
[Abstract]
[Full text]
[PDF]
Bleeding in patients receiving vitamin K antagonists who would have been excluded from trials on which the indication for anticoagulation was based
- Marcel Levi, G. Kees Hovingh, Suzanne C. Cannegieter, Marinus Vermeulen, Harry R. Büller, and Frits R. Rosendaal
Blood 2008; 111: 4471-4476.
[Abstract]
[Full text]
[PDF]
Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95
- Anja Möricke, Alfred Reiter, Martin Zimmermann, Helmut Gadner, Martin Stanulla, Michael Dördelmann, Lutz Löning, Rita Beier, Wolf-Dieter Ludwig, Richard Ratei, Jochen Harbott, Joachim Boos, Georg Mann, Felix Niggli, Andreas Feldges, Günter Henze, Karl Welte, Jörn-Dirk Beck, Thomas Klingebiel, Charlotte Niemeyer, Felix Zintl, Udo Bode, Christian Urban, Helmut Wehinger, Dietrich Niethammer, Hansjörg Riehm, and Martin Schrappe, for the German-Austrian-Swiss ALL-BFM Study Group
Blood 2008; 111: 4477-4489.
[Abstract]
[Full text]
[PDF]
An FLT3 gene-expression signature predicts clinical outcome in normal karyotype AML
- Lars Bullinger, Konstanze Döhner, Raphael Kranz, Christoph Stirner, Stefan Fröhling, Claudia Scholl, Young H. Kim, Richard F. Schlenk, Robert Tibshirani, Hartmut Döhner, and Jonathan R. Pollack
Blood 2008; 111: 4490-4495.
[Abstract]
[Full text]
[PDF]
|
|
